405 filings
Page 10 of 21
6-K
pqdbexru7al3z
31 Jul 17
Primary Document
12:00am
6-K
sgmmt
27 Jul 17
Primary Document
12:00am
424B5
z1vrm4xjghguy8f2g
18 Jul 17
Prospectus supplement for primary offering
12:00am
424B3
j4mcl
18 Jul 17
Prospectus supplement
12:00am
424B5
oi165ls w2uo
18 Jul 17
Prospectus supplement for primary offering
12:00am
EFFECT
3yijbrdo
17 Jul 17
Notice of effectiveness
12:00am
CORRESP
pgvf2fyv3x zbuozvuh6
14 Jul 17
Correspondence with SEC
12:00am
F-3/A
854va
14 Jul 17
Shelf registration (foreign) (amended)
12:00am
6-K
uc2ig
11 Jul 17
Primary Document
12:00am
F-3/A
i3s 9slemje
11 Jul 17
Shelf registration (foreign) (amended)
12:00am
6-K
u9j28aqd5ov wj5
30 Jun 17
Primary Document
12:00am
6-K
5u9n67wz7lvd65mx q0p
6 Jun 17
Intellipharmaceutics Announces Launch of Generic Seroquel XR® by Mallinckrodt
12:00am
6-K
psh1g7sz
30 May 17
Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement to Replace Expiring Shelf Registration Statement
12:00am
F-3/A
aom0iu
30 May 17
Shelf registration (foreign) (amended)
12:00am
F-3
7sd67p0kbic
26 May 17
Shelf registration (foreign)
12:00am
6-K
5332r5u
24 May 17
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical
12:00am
6-K
3uqviigej2tvkepjps
10 May 17
Primary Document
12:00am
6-K
zeewo fnl
19 Apr 17
Intellipharmaceutics Reports Director Election Results
12:00am
6-K
d9cjxu b27387o6
12 Apr 17
Primary Document
12:00am
6-K
wc7fn4d3x
10 Apr 17
Intellipharmaceutics Announces Patent Litigation by Purdue against its RexistaTM Abuse-Deterrent Extended-Release Oxycodone
12:00am